Literature DB >> 27228545

IL-10 gene polymorphism is associated with preschool atopy and early-life recurrent wheezing after bronchiolitis in infancy.

Matti Korppi1, Kirsi Nuolivirta2, Eero Lauhkonen3, Annukka Holster2, Johanna Teräsjärvi4, Juho Vuononvirta4, Merja Helminen3, Qiushui He4,5, Petri Koponen1.   

Abstract

BACKGROUND: Variations in the genes that regulate innate immunity responses may be associated with susceptibility to asthma or atopy after early-life bronchiolitis. The aim of this study was to evaluate the association between four different polymorphisms of the IL-10 gene at rs1800871, rs1800872, rs1800890, and rs1800896, either alone or in combination, and post-bronchiolitis asthma or allergies at 5-7 years of age.
METHODS: Data on single nucleotide polymorphisms (SNP) of IL-10 rs1800896 (-1082G/A), rs1800871 (-819C/T), rs1800872 (-592C/A), and IL-10 rs1800890 (-3575T/A) were available for 135 children. Polymorphisms and their associations with asthma and allergies were studied in 135 preschool-aged children who had been hospitalized for bronchiolitis at age 0-6 months. Their parents were interviewed to record the children's history with asthma and allergies from infancy to the present.
RESULTS: At 6.4 years (mean), asthma was present in 17 children (12.6%), while recurrent wheezing during the first 7 years of life was present in 39 (28.9%) children. Fifty-three (39.3%) study participants had current atopy (atopic eczema or allergic rhinitis). Eight (72%) of 11 children with the IL-10 rs1800896, IL-10 rs1800871, and IL-10 rs1800872 combination AA + CT + CA had current atopy (P = 0.02 vs. 38% in other genotype combinations). Twenty-three (56%) children with the IL-10 rs1800871C/T or IL-10 rs1800872C/A genotype had present atopy versus 34 (38%) with other IL-10 genotypes (P = 0.03). Between 2 years and 3 years of age, 27% of ATA haplotype carriers had asthma versus 13.7% of other haplotype carriers (P = 0.02).
CONCLUSIONS: IL-10 polymorphisms at rs1800871, rs1800872, rs1800890, and rs1800896 seem to be associated with elevated allergies and/or recurrent wheezing risk in later childhood, after early-life bronchiolitis. Pediatr Pulmonol. 2017;52:14-20.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  RSV; asthma; atopic dermatitis; atopy; bronchiolitis; genes; interleukin-10; polymorphism; recurrent wheezing

Mesh:

Substances:

Year:  2016        PMID: 27228545     DOI: 10.1002/ppul.23489

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  5 in total

1.  Proteome analysis of bronchoalveolar lavage from calves infected with bovine respiratory syncytial virus-Insights in pathogenesis and perspectives for new treatments.

Authors:  Sara Hägglund; Krister Blodörn; Katarina Näslund; Karin Vargmar; Sara Bergström Lind; Jia Mi; Mariluz Araínga; Sabine Riffault; Geraldine Taylor; John Pringle; Jean François Valarcher
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

2.  Cytokine Gene Polymorphisms in Saudi Patients With Atopic Dermatitis: A Case-Control Study.

Authors:  Ghaleb Bin Huraib; Fahad Al Harthi; Misbahul Arfin; Mohammed Al-Sugheyr; Sadaf Rizvi; Abdulrahaman Al-Asmari
Journal:  Biomark Insights       Date:  2018-06-04

3.  IL-10 polymorphisms +434T/C, +504G/T, and -2849C/T may predispose to tubulointersititial nephritis and uveitis in pediatric population.

Authors:  Sari Rytkönen; Jarmo Ritari; Juha Peräsaari; Ville Saarela; Matti Nuutinen; Timo Jahnukainen
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

4.  Association between respiratory syncytial virus hospitalization in infancy and childhood asthma.

Authors:  Jonathan Coutts; John Fullarton; Carole Morris; ElizaBeth Grubb; Scot Buchan; Barry Rodgers-Gray; Richard Thwaites
Journal:  Pediatr Pulmonol       Date:  2020-02-10

5.  Risk factors for recurrent wheezing after bronchiolitis in infants: 2-year follow up in China.

Authors:  Sainan Chen; Wenjing Gu; Min Wu; Chuangli Hao; Canhong Zhu; Xuejun Shao; Yuqing Wang
Journal:  BMC Infect Dis       Date:  2021-03-10       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.